Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension

被引:13
作者
Zhang, Duan-zhen [1 ]
Zhu, Xian-yang [1 ]
Meng, Jing [1 ]
Xue, Hong-mei [1 ]
Sheng, Xiao-tang [1 ]
Han, Xiu-min [1 ]
Cui, Chun-Sheng [1 ]
Wang, Qi-guang [1 ]
Zhang, Po [1 ]
机构
[1] Shenyang No Hosp, Dept Congenital Heart Dis, Shenyang 110016, Peoples R China
关键词
Pulmonary arterial hypertension; Vasoreactivity test; Hemodynamics; Congenital heart defect; INHALED NITRIC-OXIDE; AEROSOLIZED ILOPROST; VASODILATOR CAPACITY; VASCULAR-RESISTANCE; DISEASE; CHILDREN; THERAPY; BOSENTAN; GUIDELINES;
D O I
10.1016/j.ijcard.2010.04.093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Detection of pulmonary vasoreactivity is important for the evaluation of patient with pulmonary arterial hypertension (PAH). The present study aimed to investigate the acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects (CHDs) and severe PAH. Patients and methods: From Mar 2007 to Nov 2009, 75 patients with severe PAH secondary to left-to-right shunt CHDs underwent acute vasodilator test using aerosolized iloprost (n=50) or intravenous adenosine (n=25). The hemodynamics were detected and analyzed. Results: Decreased mean pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) were observed in 39 and 43 patients in the iloprost group, and in 16 and 19 patients in the adenosine group, respectively. However, the mean PAP was higher than 40 mm Hg in both groups. No significant difference was observed in the age and baseline hemodynamics between the patients with the decrease of PVR and mean pulmonary-to-aortic pressure (Pp/Ps) ratio greater than 10% and the remaining patients. Adenosine decreased both PAP and systemic arterial pressure significantly, while iloprost inhalation selectively reduced the PAP and increased the oxygen saturation of femoral arterial blood and the pulmonary-to-systemic flow (Qp/Qs) ratio. Compared with adenosine, iloprost caused a more profound decline in the Pp/Ps ratio, PVR and pulmonary-to-systemic vascular resistance ratio, and increase in the Qp/Qs ratio. Conclusions: The acute haemodynamic responses to adenosine and iloprost varied among the patients with CHDs and severe PAH. Different to adenosine, inhaled iloprost exerted selective pulmonary vasodilative effects and was beneficial for pulmonary gas exchange. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:433 / 437
页数:5
相关论文
共 50 条
  • [31] Adult Congenital Heart Disease and Pulmonary Arterial Hypertension: The Texas Adult Congenital Heart Program Experience
    Franklin, Wayne J.
    Parekh, Dhaval R.
    Safdar, Zeenat
    POSTGRADUATE MEDICINE, 2011, 123 (06) : 32 - 45
  • [32] Pulmonary arterial hypertension treatment with bosentan in pediatric patients with congenital heart disease
    Romero Jimenez, Rosa M.
    Garcia Sanchez, Raquel
    Gimenez Manzorro, Alvaro
    Martinez Fernandez-Llamazares, Cecilia
    Sanjurjo Saez, Maria
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 347 - 347
  • [33] Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension
    Wang, Lan
    Jin, Yuan-Zhe
    Zhao, Qin-Hua
    Jiang, Rong
    Wu, Wen-hui
    Gong, Su-Gang
    He, Jing
    Liu, Jin-Ming
    Jing, Zhi-Cheng
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 3353 - 3360
  • [34] Acute hemodynamic response of infused fasudil in patients with pulmonary arterial hypertension: A randomized, controlled, crossover study
    Jiang, Xin
    Wang, Yue-Fu
    Zhao, Qin-Hua
    Jiang, Rong
    Wu, Yan
    Peng, Fu-Hua
    Xu, Xi-Qi
    Wang, Lan
    He, Jing
    Jing, Zhi-Cheng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (01) : 61 - 65
  • [35] Aerosolized Iloprost for Pulmonary Vasoreactivity Testing in Children With Long-Standing Pulmonary Hypertension Related to Congenital Heart Disease
    Limsuwan, Alisa
    Khosithseth, Anan
    Wanichkul, Suthep
    Khowsathit, Pongsak
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 73 (01) : 98 - 104
  • [36] Clinical and Hemodynamic Correlates of Pulmonary Arterial Stiffness in Incident, Untreated Patients With Idiopathic Pulmonary Arterial Hypertension
    Chemla, Denis
    Weatherald, Jason
    Lau, Edmund M. T.
    Savale, Laurent
    Boucly, Athenals
    Attal, Pierre
    Jais, Xavier
    Parent, Florence
    Girerd, Barbara
    Simonneau, Gerald
    Montani, David
    Humbert, Marc
    Sitbon, Olivier
    Herve, Philippe
    CHEST, 2018, 154 (04) : 882 - 892
  • [37] Inhaled Iloprost Plus Oral Sildenafil in Patients With Severe Pulmonary Arterial Hypertension Delays the Need for Lung Transplantation
    Lopez-Meseguer, M.
    Berastegui, C.
    Monforte, V.
    Bravo, C.
    Domingo, E.
    Roman, A.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (06) : 2347 - 2350
  • [38] 4D flow cardiac MRI to assess pulmonary blood flow in patients with pulmonary arterial hypertension associated with congenital heart disease
    Valdeolmillos, Estibaliz
    Sakhi, Hichem
    Tortigue, Marine
    Audie, Marion
    Isorni, Marc-Antoine
    Lecerf, Florence
    Sitbon, Olivier
    Montani, David
    Jais, Xavier
    Savale, Laurent
    Humbert, Marc
    Azarine, Arshid
    Hascoet, Sebastien
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2024, 105 (7-8) : 266 - 272
  • [39] Pulmonary arterial hypertension in congenital heart disease
    Ferrero, Paolo
    Krishnathasan, Kaushiga
    Constantine, Andrew
    Chessa, Massimo
    Dimopoulos, Konstantinos
    HEART, 2024, 110 (18) : 1145 - 1152
  • [40] Effects of Inhaled Iloprost on Exercise Capacity, Quality of Life, and Cardiac Function in Patients With Pulmonary Arterial Hypertension Secondary to Congenital Heart Disease (the Eisenmenger Syndrome) (from the EIGER Study)
    Cha, Kwang Soo
    Cho, Kyoung Im
    Seo, Jeong Sook
    Choi, Jung Hyun
    Park, Yong Hyun
    Yang, Dong Heon
    Hong, Geu Ru
    Kim, Dong Soo
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (11) : 1834 - 1839